National Genecular Institute Testifies in Favor of Iowa Bill to Ease Restrictions on Stem Cell Research
News Feb 22, 2007
The National Genecular Institute (NGI) has announced Dr. Tannin Fuja, director of research and chief scientific officer, will testify a public hearing in support of the Iowa Stem Cell Research and Cures Initiative.
The Bill, House File 287, would ease restrictions on stem cell research and enable medical researchers to create embryonic stem cells through cloning in order to find cures and treatments for diseases. It was recently approved by the Iowa House Human Resources Committee and will be the focus of public hearing at the Iowa State House in Des Moines.
Dr. Fuja, who is also an adjunct faculty member at the University of Iowa, is leading NGI’s development of the world’s largest global biotrust facility in conjunction with the University of Iowa.
Hundreds of thousands of tissue and DNA samples will be collected, cultivated, stored and sold to third-party researchers for studies into diseases such as Parkinson’s disease, Alzheimer’s disease, certain cancers and MS.
“While embryonic stem cell research is currently being conducted in Iowa, under the current law this research cannot be used for treatment and therapies,” said Fuja.
“Embyronic stem cell research holds tremendous promise for improving the lives of millions of Americans and offers a powerful tool in the advancement of biomedical discovery and cure that is critically distinct from that of adult or fetal stem cell research. This is why we strongly urge the Iowa congress to support the repeal of the ban on embryonic stem cell research in Iowa,” Fuja continued.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019